Biotech and Pharma Stocks Research News; Q1 Publishing Research Report on Verisante Technology, Inc. (TSX-V: VRS) (OTC: VRSEF)
May 16, 2011 - Investorideas.com newswire, a leader in investor stock research including biotech stocks, publishes the following Q1 Publishing Research Report on Verisante Technology, Inc. ( TSX-V: VRS) (PINK SHEETS: VRSEF). Q1 Publishing is an independent investment research firm which offers research on effective investment tools to investors. (http://www.q1publishing.com/investmenttools/reports)
Investorideas.com Newswire features third party research and equity reports from multiple research firms from within the investment community.
Jump on this Rapidly Unfolding Med-Tech Innovation Now
By Andrew Mickey, Q1 Publishing
We've only had this feeling a few times before.
It's the feeling we're onto something big - real big - at a very early state.
The same feeling we had about fertilizer stocks in July 2006. The same feeling about the Nintendo Wii when it exploded in Japan and its US launch was still months away. Or when Intuitive Surgical's robotic surgery technology was just making it into hospitals.
You know the feeling you're sitting on your next five- or 10-bagger, you understand it, you know it's big, and you're just waiting for everyone else to figure it out.
Frankly, it's a rare feeling. It's even rarer in a market like this where everything seems priced for perfection.
It's rare, but it's not impossible. Right now, we've got that feeling one small and fast-growing company is about to change a lucrative medical field for the better. And do it soon.
But we're not alone here. Some of the leading medical journals and magazines see the enormous potential we've spotted.
Biotechnology Focus magazine calls this development "ingenious."
The BC Medical Journal says, "Preliminary clinical results have so far demonstrated 100% efficacy."
Darrell Rigel, a professor of dermatology at NYU's Langone Medical Center, told MIT's Technology Review journal there's "a need" for innovations like this.
Despite the medical community's excitement, it still hasn't gone mainstream…yet.
Our window of opportunity to buy into Verisante Technology (TSX-V: VRS or OTCQX: VRSEF) will not be open forever.
Right now Verisante is a small $35 million company, just on the verge of leading medical technology revolution, has shown stellar preliminary clinical results, and based on market comparables is a ten-bagger-in-waiting.
In a few months, all that will be history and Verisante will be value much higher. Let's start at the beginning.
The Next Big Med-Tech Winner
If you're like me, you've learned (the hard and often expensive way) to become highly skeptical when it comes to new technologies.
They consistently over promise and under deliver.
Well, I think Verisante has under promised and is set to over deliver.
Verisante is aquickly emerging medical technology (med-tech) company which, despite its small size, is on the verge of doing something truly revolutionary.
The technology has been in development for 10 years. Its development has been led by some of the world's leading cancer researchers. It has received funding from leading cancer research organizations including the BC Cancer Society.
And, although it's technology has the potential to change almost every field of medicine, it's initially focused on a subsector of the medical field that's overdue for innovation.
Now with a recent $5 million capital infusion to take it to final commercialization, Verisante is poised to make it very big, very soon.
10 Years of Development About to Pay Off
Verisante is has entered the final approval stages for its proprietary cancer screening device.
On the surface, Verisante's Aura device is really simple. It detects cancerous cells by an advanced laser scanning system. And it does it with an astonishing rate of accuracy.
Think of a price scanner at the grocery store. It scans a bar code and tells you the price. Verisante's Aura concern detection device scans a skin lesion and tells you if it's cancerous. (For a complete explanation of how it works, follow this link to a recent feature on Canada's BTV )
Again, it really is a simple concept. But the science behind it is much more advanced than that.
Most importantly though, the Aura has shown the potential to revolutionize cancer detection and save a lot of lives and money in the process.
Verisante has targeted melanoma, one of the most feared and costly to treat cancers, for its initial launch.
Future Market Domination
The Aura device has shown remarkable accuracy and consistency in detecting melanoma at a very early stage (more details below).
Skin cancer is one of the most common forms of cancer. More than two million Americans are diagnosed with it each year. It will affect one in five US residents. And at least 40% of Americans can expect to get non-melanoma skin cancer before they turn 65.
Melanoma specifically one of the most deadly types of cancer. If detected in the Stage I it has an 85% survival rate. In Stage IV the survival rate falls to an ominous 15%.
Melanoma and skin cancer is costly too. It costs $1.5 billion a year to treat melanoma alone.
Despite the high costs of treatment and its deadly nature, there has been little advancement in detection.
For decades, dermatologists have relied on their eyes and patients to self-identify abnormal growth in moles and skin lesions. These crude methods successfully identify about one in three cases of melanoma.
Recently, however, the markets had high expectations that one of Verisante's competitors made a major breakthrough in melanoma detection. And investors were willing to pay top dollar merely speculating the technology worked effectively and consistently enough for regulatory approval.
Why Verisante is a True 10-Bagger
Knowing differences between the Verisante's and MELA Sciences (NASDAQ:MELA) – Verisante's closes competitor - devices reveals the true opportunity here.
MELA has been one of the most closely watched med-tech device stocks over the last year.
MELA's melanoma detection device, MelaFind, was in the final stages of regulatory approval heading into the end of 2010.
Investors were willing to risk getting in early because the upside potential was massive. If approved, MELA would be dominating a mult-billion dollar market virtually overnight.
MELA shares ran to more than $9 per share in anticipation of U.S. Food and Drug Administration (FDA) approval. At its peak, the total market value exceeded $200 million. Keep in mind, MelaFind is only aimed at melanoma and not the many other cancers Verisante's Aura has the potential to be used to detect. And it still was worth $200 million.
Then last November the FDA rejected MELA's device and its shares plummeted.
But here's the thing, MELA's device was rejected for a number of reasons that Verisante will not be affected by.
MELA was rejected because of its low degree of accuracy and large number of false positives.
In my opinion, MelaFind was basically not much more effective than what a dermatologist can determine just by looking at a suspicious mole.
The FDA requires a device to have a certain level of accuracy and consistency. MelaFind had neither.
Now MELA is going to need more studies and more capital to complete those studies. Yet it still has a market value almost three times higher than Verisante.
Key to Success: The Molecular Signature
The key difference between MELA's device and Verisante's is how they identify potentially cancerous cells.
MelaFind takes a picture of a mole or lesion. It then analyzes it against a database of images of confirmed melanoma cases. It uses a proprietary algorithm to compare shapes, sizes, and abnormalities of the lesions. This method didn't produce the accuracy or consistency required by the FDA.
Verisante's device works in a completely different way.
The Aura device analyzes what I call the "molecular signature" of the mole or lesion to determine whether it's likely cancerous or not.
The Aura uses Raman spectroscopy to detect the potential cancer at the molecular level. The studies conducted on the Aura device confirm how effective this process is.
In a six-year clinical trial conducted at the University of British Columbia's dermatology department and Vancouver General Hospital (which has 80,000 dermatoligical patients per year), the Aura device has detected melanoma with incredible accuracy and consistency.
Over a preliminary sample of 274 lesions, the Aura identified 45 melanoma occurrences. Thirty four of those occurrences identified by Aura were confirmed by a biopsy.
These preliminary results give melanoma a 100% accuracy rate and, as a testament to the reliability of the device, a 70% specificity.
These rates are critical part of the regulatory review process. The accuracy rate shows Aura works. The specificity rate shows Aura doesn't give too many "false positive" diagnoses. After all, you can't have a device that gives too many false positives. It would be worthless if it did.
This kind of accuracy and specificity is the critical difference for Verisante. And it shows how revolutionary this product is.
But it takes more than a better mousetrap to be successful. And Verisante has laid out a business model that has been exceptionally profitable for many of the leading companies in the world.
A Dermatologist's Perspective
The most impressive part of Verisante is its business model for commercializing the Aura device.
Once the Aura is approved, Verisante has planned a way to generate a profit by both selling its Aura devices and still earning an ongoing stream of revenue.
Verisante is using the "razor and blade model."
Do you think Gillette makes a lot of money selling a Mach 3 razor for $12? They do, but they make a lot more selling $4 razors month after month after month. Verisante is using the same strategy.
Let's take it from a dermatologist's perspective.
A skin doctor would be able to buy an Aura device and generate a lot of revenue from it. They would be able to charge anywhere from $100 to $500 for a cancer screening and do it for thousands of patients each year.
Many, I'm sure, would be able to pay at least $50,000 for a device that could generate between $100,000 to $1 million a year in revenue from it.
Verisante will likely be able to be able to build Aura devices for about $10,000. This will likely improve as demand increases and economies of scale are achieved, but let's take the more conservative $10,000 estimate. Verisante would be able to sell the device for between $30,000 and $60,000 to dermatologists.
That's a solid margin. The real money, however, comes from the continuous revenue it would receive. The "blades" part of the razor and blade model.
Each screening with the Aura device requires a new tip. The tip includes a lens and other proprietary features to prevent misdiagnosis. Verisante sells the specialized tips required for each use. The tips would likely cost dermatologists $10 each and significantly less to produce.
Verisante would be generating between $20,000 and $50,000 in gross profit per sale of each device. Then it would generate anywhere from $10,000 to $100,000 in additional revenues from the specialized tips from each device owner per year, every year.
Multiply those numbers out over a few hundred dermatologists (although there are thousands around the world) and you get some staggering numbers.
It's a massive opportunity which has the potential to make Verisante a $1 billion company as the Aura spreads across high-demand markets in Canada, Europe, and the United States.
On top of that, it's important to keep in mind that's just with melanoma. Verisante's technology has been proven to successfully identify many different types of cancers. Early trials have shown its effectiveness in identifying lung, cervical, and colon cancer.
Melanoma is just where Verisante's technology has had most of the research and testing geared towards. Once you add in potential opportunities in the other cancers, Verisante's potential is exponentially higher over the long run.
Nearing the Finish Line
Verisante seems to have it all. It's better, cheaper, and potentially very profitable. But the key with any investment in medical technology is completing the regulatory approval processes.
Verisante is aiming at completing the regularity approval process in a faster, less-costly way.
First, most of the expensive and time-consuming research is already completed. The Aura device has been in development for about 10 years. And it already has one six-year study completed.
Now Verisante is in the final stages of approval with Canadian medical authorities. Final approval is expected to be made by the end of 2011.
After that, Verisante has already started the European approval process. It expects to the "CE Mark" (the symbol of European approval) to be granted as early as the end of 2011.
If and when this is approved, Verisante has instant access to markets in the European Union, South Africa, and Australia.
Finally, with European and Canadian approval in hand, its' going to then move to the United States. It needs more studies for U.S. approval, but like many other drugs and medical devices, it's a lot more likely to get approval in the United States after Canada and Europe give the official thumbs up.
A Big Winner in the Making
Verisante Technology (TSX-V:VRS or OTCQX:VRSEF) is in position to have an exciting few months ahead as the story unfolds and even more great years beyond that.
It has all the elements of a giant med-tech success story.
It has superior, proven technology.
It has years of costly and time-consuming research behind it.
It's very near to final regulatory approval in Canada.
It has shown the potential to save a lot of lives too.
On top of all that, Verisante was recently able to attract an addition $5 million capital infusion in a market where med-tech and biotech aren't getting very much venture capital.
Perhaps most importantly, Verisante has huge growth potential. At a mere $35 market cap, the upside is tremendous. Remember, its closest competitor, MELAScience, had a market value of about $200 million just in anticipation it would be successful. And after it got rejected by the FDA, it still has a $90 million market value.
That's the kind of potential here where once the Aura is approved; Verisante is on its way to being worth $1 billion.
Head over to Verisante.com to see for yourself.
Andrew Mickey
Chief Investment Strategist, Q1 Publishing
Disclosure: The editor does not own shares and is not paid by any of the companies mentioned for distribution of this report. It is, however, an open recommendation in Q1 Publishing's President's List premium research service.
If you like ideas and research like this, the President's List is a premium investment research focused on the maximum risk-reward opportunities available anywhere in the world. You can learn more about a no-risk trial offer here. Legal Disclaimer : The information contained on this e-mail and in other Q1 Publishing communications is intended for general information purposes only. Q1 Publishing has not taken into account the specific investment objectives of any particular investor. You should always seek the counsel of a professional financial advisor before purchasing or selling stock. Directors, employees and outside contributors to Q1 Publishing may hold substantial positions in the recommended securities and may increase or decrease such positions without notice. We believe the sources of information to be reliable but Q1 Publishing does not guarantee the accuracy or completeness of the information provided on this website or in other Q1 communications, and expressly disclaims liability for any errors or omissions that may be contained in the information
More research;
To view a profile on Verisante Technology, Inc. ( TSX-V: VRS ) (PINK SHEETS: VRSEF) as aired on BTV, click on the following link
http://www.youtube.com/verisante#p/u/2/PHugTxLXQGI
To view the Zacks Investment Research Initiation Report on Verisante Technology, Inc. ( TSX-V: VRS ) (PINK SHEETS: VRSEF) click on the following link:
http://verisante.com/docs/verisante_zacks.pdf
To view media articles and stories on Verisante Technology, Inc. ( TSX-V: VRS ) (PINK SHEETS: VRSEF) click on the following link:
http://verisante.com/news/media/
Investorideas.com disclaimer and disclosure � the following news is a paid news release distribution (one thousand for 2 releases) Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp
The published report by Q1 Publishing is the property of Q1 Publishing and is not the opinion of Investorideas.com. Investorideas.com is a news publisher of third party research.
Monday, May 16, 2011
Oil and Gas Stocks News; American Petro-Hunter (OTCBB: AAPH) Announces Drilling of Horizontal Well at North Oklahoma Project
SCOTTSDALE, AZ � May 16, 2011 (Investorideas.com energy newswire) - American Petro-Hunter, Inc. (OTC.BB:AAPH) ("American Petro-Hunter" or the "Company") is very pleased to announce that drilling operations have commenced at the Company's newest well site on the North Oklahoma Project. Today, drilling equipment has been mobilized with preparations underway for the Company's first horizontal well, designated NOM1H.
NOM1H is scheduled to spud tomorrow and is the first of an anticipated series of horizontal wells designed to exploit the Mississippi Formation. The over 100-foot thick limestone is the central focus of the well documented recent drilling and leasing frenzy in Oklahoma. Hundreds of horizontal wells have been executed, planned and/or implemented by companies such as Sandridge and Calyx in recent months. Of particular note, Sandridge announced in its latest year end filing that it had drilled and completed 29 wells with 8 remaining to be completed in the area.
The NOM1H well is anticipated to take several weeks to reach its engineered total depth, following which it will undergo a period of testing and evaluation. With the high success rate of analog wells in the area American Petro-Hunter has great hopes for a successful producer in this highly sought after oil play.
As the activity in the area has become extremely competitive, and information regarding detailed production rates of commercial quantities of oil and natural gas is increasingly regarded as tightly held information, the Company will endeavor to update stakeholders on a timely basis with drilling results as such information becomes available from the operator.
Company President Robert McIntosh states, "We are extremely pleased to have begun our very first venture into the realm of horizontal well drilling. This venture offers us a possibility like no other, to immediately and significantly increase our oil production. The opportunity to be right in the heart of the hunt for 'big oil' in Oklahoma is an exciting step for the Company and we hope will prove to be beneficial for all concerned."
About American Petro-Hunter, Inc. (OTCBB: AAPH)
The Company is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas with new drilling activity and production underway at the North Oklahoma Oil Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the "hunt" for domestic petroleum assets. Visit us at: www.americanpetrohunter.com
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of our exploration program at our properties and any anticipated future production. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with petroleum exploration and development stage exploration companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-KSB for the most recent fiscal year, our quarterly reports on Form 10-QSB and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
American Petro-Hunter, Inc.
Robert McIntosh
President & C.E.O.
To find out more about American Petro-Hunter, Inc. (OTC.BB:AAPH), visit our website at www.americanpetrohunter.com
Contact:
Investor Relations:
Mountainview IR Services, Inc.
1-888-521-7762
investors@americanpetrohunterinc.com
SCOTTSDALE, AZ � May 16, 2011 (Investorideas.com energy newswire) - American Petro-Hunter, Inc. (OTC.BB:AAPH) ("American Petro-Hunter" or the "Company") is very pleased to announce that drilling operations have commenced at the Company's newest well site on the North Oklahoma Project. Today, drilling equipment has been mobilized with preparations underway for the Company's first horizontal well, designated NOM1H.
NOM1H is scheduled to spud tomorrow and is the first of an anticipated series of horizontal wells designed to exploit the Mississippi Formation. The over 100-foot thick limestone is the central focus of the well documented recent drilling and leasing frenzy in Oklahoma. Hundreds of horizontal wells have been executed, planned and/or implemented by companies such as Sandridge and Calyx in recent months. Of particular note, Sandridge announced in its latest year end filing that it had drilled and completed 29 wells with 8 remaining to be completed in the area.
The NOM1H well is anticipated to take several weeks to reach its engineered total depth, following which it will undergo a period of testing and evaluation. With the high success rate of analog wells in the area American Petro-Hunter has great hopes for a successful producer in this highly sought after oil play.
As the activity in the area has become extremely competitive, and information regarding detailed production rates of commercial quantities of oil and natural gas is increasingly regarded as tightly held information, the Company will endeavor to update stakeholders on a timely basis with drilling results as such information becomes available from the operator.
Company President Robert McIntosh states, "We are extremely pleased to have begun our very first venture into the realm of horizontal well drilling. This venture offers us a possibility like no other, to immediately and significantly increase our oil production. The opportunity to be right in the heart of the hunt for 'big oil' in Oklahoma is an exciting step for the Company and we hope will prove to be beneficial for all concerned."
About American Petro-Hunter, Inc. (OTCBB: AAPH)
The Company is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas with new drilling activity and production underway at the North Oklahoma Oil Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the "hunt" for domestic petroleum assets. Visit us at: www.americanpetrohunter.com
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of our exploration program at our properties and any anticipated future production. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with petroleum exploration and development stage exploration companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-KSB for the most recent fiscal year, our quarterly reports on Form 10-QSB and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
American Petro-Hunter, Inc.
Robert McIntosh
President & C.E.O.
To find out more about American Petro-Hunter, Inc. (OTC.BB:AAPH), visit our website at www.americanpetrohunter.com
Contact:
Investor Relations:
Mountainview IR Services, Inc.
1-888-521-7762
investors@americanpetrohunterinc.com
Visit the AAPH showcase profile at Investorideas.com
Request News and Info on AAPH
Disclosure, Disclaimer/ AAPH is a paid advertising client on Investorideas.com.
American Petro-hunter Inc. (AAPH.OB) Oct 2010 - one month showcase energy stock on Investorideas.com and energy portals and blogs (three thousand per month)
Request News and Info on AAPH
Disclosure, Disclaimer/ AAPH is a paid advertising client on Investorideas.com.
American Petro-hunter Inc. (AAPH.OB) Oct 2010 - one month showcase energy stock on Investorideas.com and energy portals and blogs (three thousand per month)
Oil and Gas News; American Petro-Hunter (OTCBB: AAPH) Announces Drilling of Horizontal Well at North Oklahoma Project
SCOTTSDALE, AZ -- -- May 16, 2011 – American Petro-Hunter, Inc. (OTCBB: AAPH) (“American Petro-Hunter” or the “Company”) is very pleased to announce that drilling operations have commenced at the Company’s newest well site on the North Oklahoma Project. Today, drilling equipment has been mobilized with preparations underway for the Company’s first horizontal well, designated NOM1H.
NOM1H is scheduled to spud tomorrow and is the first of an anticipated series of horizontal wells designed to exploit the Mississippi Formation. The over 100 foot thick limestone is the central focus of the well documented recent drilling and leasing frenzy in Oklahoma. Hundreds of horizontal wells have been executed, planned and/or implemented by companies such as Sandridge and Calyx in recent months. Of particular note, Sandridge announced in its latest year end filing that it had drilled and completed 29 wells with 8 remaining to be completed in the area.
The NOM1H well is anticipated to take several weeks to reach its engineered total depth, following which it will undergo a period of testing and evaluation. With the high success rate of analog wells in the area American Petro-Hunter has great hopes for a successful producer in this highly sought after oil play.
As the activity in the area has become extremely competitive, and information regarding detailed production rates of commercial quantities of oil and natural gas is increasingly regarded as tightly held information, the Company will endeavor to update stakeholders on a timely basis with drilling results as such information becomes available from the operator.
Company President Robert McIntosh states “We are extremely pleased to have begun our very first venture into the realm of horizontal well drilling. This venture offers us a possibility like no other, to immediately and significantly increase our oil production. The opportunity to be right in the heart of the hunt for “big oil” in Oklahoma is an exciting step for the Company and we hope will prove to be beneficial for all concerned.”
About American Petro-Hunter, Inc. (OTCBB: AAPH)
The Company is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas and the North Oklahoma Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the “hunt” for domestic petroleum assets. Visit us at: www.americanpetrohunter.com
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of our exploration program at our properties and any anticipated future production. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with petroleum exploration and development stage exploration companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-KSB for the most recent fiscal year, our quarterly reports on Form 10-QSB and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
American Petro-Hunter, Inc.
- - - - - - - - - - - - - - - - - -
Robert McIntosh
President & C.E.O.
To find out more about American Petro-Hunter, Inc. (OTCBB: AAPH), visit our website at www.americanpetrohunter.com
Investor Relations:
Mountainview IR Services, Inc.
1-888-521-7762
investors@americanpetrohunterinc.com
American Petro-hunter Inc (OTCBB: AAPH) is a showcase Oil and Gas stock on Investorideas.com (please read disclosure and disclaimers)
Visit the showcase page on Investorideas.com
http://www.investorideas.com/CO/AAPH/
Request info:
http://www.investorideas.com/Resources/Newsletter.asp
About Investor Ideas Oil and Gas portal: OilandGasStocksNews.com is a global meeting place for investors and industry following the energy sector, within Investorideas.com. Global visitors use the site daily
to research the latest news, articles, audio, research reports and our oil and gas and natural gas stock directories.
Disclaimer: The following American Petro-Hunter Inc news is paid for by third party on behalf of showcase energy stock AAPH (averages $ 2000 per month ). Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. All investing involves risk and possible loss of full investment .
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
The research report mentioned in this article is the content and opinion of Grass Roots Research and Distribution, Inc., not Investorideas.com or its related sites.
SCOTTSDALE, AZ -- -- May 16, 2011 – American Petro-Hunter, Inc. (OTCBB: AAPH) (“American Petro-Hunter” or the “Company”) is very pleased to announce that drilling operations have commenced at the Company’s newest well site on the North Oklahoma Project. Today, drilling equipment has been mobilized with preparations underway for the Company’s first horizontal well, designated NOM1H.
NOM1H is scheduled to spud tomorrow and is the first of an anticipated series of horizontal wells designed to exploit the Mississippi Formation. The over 100 foot thick limestone is the central focus of the well documented recent drilling and leasing frenzy in Oklahoma. Hundreds of horizontal wells have been executed, planned and/or implemented by companies such as Sandridge and Calyx in recent months. Of particular note, Sandridge announced in its latest year end filing that it had drilled and completed 29 wells with 8 remaining to be completed in the area.
The NOM1H well is anticipated to take several weeks to reach its engineered total depth, following which it will undergo a period of testing and evaluation. With the high success rate of analog wells in the area American Petro-Hunter has great hopes for a successful producer in this highly sought after oil play.
As the activity in the area has become extremely competitive, and information regarding detailed production rates of commercial quantities of oil and natural gas is increasingly regarded as tightly held information, the Company will endeavor to update stakeholders on a timely basis with drilling results as such information becomes available from the operator.
Company President Robert McIntosh states “We are extremely pleased to have begun our very first venture into the realm of horizontal well drilling. This venture offers us a possibility like no other, to immediately and significantly increase our oil production. The opportunity to be right in the heart of the hunt for “big oil” in Oklahoma is an exciting step for the Company and we hope will prove to be beneficial for all concerned.”
About American Petro-Hunter, Inc. (OTCBB: AAPH)
The Company is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas and the North Oklahoma Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the “hunt” for domestic petroleum assets. Visit us at: www.americanpetrohunter.com
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of our exploration program at our properties and any anticipated future production. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with petroleum exploration and development stage exploration companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-KSB for the most recent fiscal year, our quarterly reports on Form 10-QSB and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
American Petro-Hunter, Inc.
- - - - - - - - - - - - - - - - - -
Robert McIntosh
President & C.E.O.
To find out more about American Petro-Hunter, Inc. (OTCBB: AAPH), visit our website at www.americanpetrohunter.com
Investor Relations:
Mountainview IR Services, Inc.
1-888-521-7762
investors@americanpetrohunterinc.com
American Petro-hunter Inc (OTCBB: AAPH) is a showcase Oil and Gas stock on Investorideas.com (please read disclosure and disclaimers)
Visit the showcase page on Investorideas.com
http://www.investorideas.com/CO/AAPH/
Request info:
http://www.investorideas.com/Resources/Newsletter.asp
About Investor Ideas Oil and Gas portal: OilandGasStocksNews.com is a global meeting place for investors and industry following the energy sector, within Investorideas.com. Global visitors use the site daily
to research the latest news, articles, audio, research reports and our oil and gas and natural gas stock directories.
Disclaimer: The following American Petro-Hunter Inc news is paid for by third party on behalf of showcase energy stock AAPH (averages $ 2000 per month ). Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. All investing involves risk and possible loss of full investment .
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
The research report mentioned in this article is the content and opinion of Grass Roots Research and Distribution, Inc., not Investorideas.com or its related sites.
Sunday, May 15, 2011
Gold and Mining Stocks Investors- become a Facebook.com Fan and receive free mining stocks directory
Investorideas.com invites investors trading gold and mining stocks to become a Facebook.com Fan and receive free mining stocks directory
Investors can also Register for free online mining conference, Follow the Money in Mining and Metals - Learn how to trade mining and gold stocks
http://www.investorideas.com/, a global investor research portal, specializing in sector research, including mining and gold stocks invites investors to join us on Facebook.com and get a free mining stocks directory, with over 1300 listed gold and mining stocks ($29.95 value) . The directories are part of the comprehensive investor research tools Investorideas.com offers to independent investors.
The stock directories are just one of the tools to help investors in the mining sector. This month, Investorideas.com and Smallcapvoice.com are hosting the online mining conference, Follow the Money in Mining and Metals, May 25th and 26. The online conference is free to investors with login registration.
Free Investor Sign-Up - http://www.smallcapvoice.com/ii_scv/investor-signup.html
Facebook Badge
Look for us on Facebook.com -
Investorideas.com- Investing ideas that can change the world
http://www.facebook.com/pages/Investorideascom-Investing-ideas-that-can-change-the-world/188472654518401
FACEBOOK BADGE
Investorideas.com- Investing ideas that can change the world
About our mining stocks directory:
Mining and Gold Stocks Directory - Global Mining and Gold Stocks Directory in PDF format lists over 1300 publicly traded mining companies. Mining and metals investors can research gold and mining stocks with the mining stocks directory, featuring Gold Stocks, Silver Stocks, Uranium Stocks, Copper Stocks, Zinc Stocks and Precious Metals TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading Stock Exchanges. directory features hyperlinks to stocks symbol(s), company’s URL and company’s description.
Email us at dawn@investorideas.com and let us know you have become a fan and we will email you the PDF free!
More mining stocks research - free online investor conference
Follow the Money in Mining and Metals, May 25th and 26.
The online conference is free to investors with login registration. The presentations will be an audio format with PowerPoint, averaging 10-15 minutes in length.
The event will be pre-recorded and go live May 25th starting at 9:00 a.m. EST. It will be archived for three months and available with login. The conference pages will be featured for investors at both Investorideas.com and SmallCapvoice.com.
Resource speakers include Mr. Siddharth Rajeev, Of Fundamental Research Corp, Eric Coffin from Hard Rock Analyst, Peter Grandich, Lawrence Roulston and Stephen Whiteside of TheUpTrend.com.
Learn More about the Mining Conference
http://www.investorideas.com/MSS/Conference.asp
Free Investor Sign-Up
http://www.smallcapvoice.com/ii_scv/investor-signup.html
Public Company Sign-Up
http://www.smallcapvoice.com/ii_scv/company-signup.html
About our Mining Portals:
http://www.gold-miningstocks.com/ and http://www.miningsectorstocks.com/ are research portals within the InvestorIdeas.com content umbrella, featuring industry and stock news, exclusive articles and financial columnists, audio interviews and podcasts, investor conferences, blogs, and a directory of over 1300 mining stocks.
Become an Investor Ideas Member - Get even more stock research !
Investor Ideas members get access to the most comprehensive stock directories online with 24/7 login access to water stocks, renewable energy stocks and more. Learn more: http://www.investorideas.com/membership/
Cali Van Zant: 800-665-0411 - cvanzant@investorideas.com
Offer limited to first 25 new fans
Investorideas.com invites investors trading gold and mining stocks to become a Facebook.com Fan and receive free mining stocks directory
Investors can also Register for free online mining conference, Follow the Money in Mining and Metals - Learn how to trade mining and gold stocks
http://www.investorideas.com/, a global investor research portal, specializing in sector research, including mining and gold stocks invites investors to join us on Facebook.com and get a free mining stocks directory, with over 1300 listed gold and mining stocks ($29.95 value) . The directories are part of the comprehensive investor research tools Investorideas.com offers to independent investors.
The stock directories are just one of the tools to help investors in the mining sector. This month, Investorideas.com and Smallcapvoice.com are hosting the online mining conference, Follow the Money in Mining and Metals, May 25th and 26. The online conference is free to investors with login registration.
Free Investor Sign-Up - http://www.smallcapvoice.com/ii_scv/investor-signup.html
Facebook Badge
Look for us on Facebook.com -
Investorideas.com- Investing ideas that can change the world
http://www.facebook.com/pages/Investorideascom-Investing-ideas-that-can-change-the-world/188472654518401
FACEBOOK BADGE
Investorideas.com- Investing ideas that can change the world
About our mining stocks directory:
Mining and Gold Stocks Directory - Global Mining and Gold Stocks Directory in PDF format lists over 1300 publicly traded mining companies. Mining and metals investors can research gold and mining stocks with the mining stocks directory, featuring Gold Stocks, Silver Stocks, Uranium Stocks, Copper Stocks, Zinc Stocks and Precious Metals TSX, TSX Venture, OTC, NASDAQ, AMEX, NYSE, ASX, AIM and other leading Stock Exchanges. directory features hyperlinks to stocks symbol(s), company’s URL and company’s description.
Email us at dawn@investorideas.com and let us know you have become a fan and we will email you the PDF free!
More mining stocks research - free online investor conference
Follow the Money in Mining and Metals, May 25th and 26.
The online conference is free to investors with login registration. The presentations will be an audio format with PowerPoint, averaging 10-15 minutes in length.
The event will be pre-recorded and go live May 25th starting at 9:00 a.m. EST. It will be archived for three months and available with login. The conference pages will be featured for investors at both Investorideas.com and SmallCapvoice.com.
Resource speakers include Mr. Siddharth Rajeev, Of Fundamental Research Corp, Eric Coffin from Hard Rock Analyst, Peter Grandich, Lawrence Roulston and Stephen Whiteside of TheUpTrend.com.
Learn More about the Mining Conference
http://www.investorideas.com/MSS/Conference.asp
Free Investor Sign-Up
http://www.smallcapvoice.com/ii_scv/investor-signup.html
Public Company Sign-Up
http://www.smallcapvoice.com/ii_scv/company-signup.html
About our Mining Portals:
http://www.gold-miningstocks.com/ and http://www.miningsectorstocks.com/ are research portals within the InvestorIdeas.com content umbrella, featuring industry and stock news, exclusive articles and financial columnists, audio interviews and podcasts, investor conferences, blogs, and a directory of over 1300 mining stocks.
Become an Investor Ideas Member - Get even more stock research !
Investor Ideas members get access to the most comprehensive stock directories online with 24/7 login access to water stocks, renewable energy stocks and more. Learn more: http://www.investorideas.com/membership/
Cali Van Zant: 800-665-0411 - cvanzant@investorideas.com
Offer limited to first 25 new fans
Friday, May 13, 2011
Mining and Gold Stock News; Goldcorp (TSX: G, NYSE: GG), (TSX.V: CUI) (OTC: CUIRF), (TSXV: UVR), (TSX-V: YLL and Frankfurt: YAB) (TSX-V: RUN) (US OTC: RFXRF) (FRANKFURT: C8Q), (TSX-V: TRM) at Mining and Metals
May 13, 2011 - www.Investorideas.com and www.SmallCapVoice.com, leaders in small cap investor stock announce publicly trading mining stocks and presenters at this month’s free online investor conference discussing the future of mining stocks. Presenting Mining Stocks Include; (TSX: G, NYSE: GG), (TSX.V: CUI), (TSXV: UVR), (TSX-V: YLL), (TSX-V: RUN) and (TSX-V: TRM).
Mining company, Goldcorp (TSX: G, NYSE: GG)will present as the keynote mining stock at online mining conference, Follow the Money in Mining and Metals, May 25 th and 26.
The online conference is free to investors with login registration. The presentations will be an audio format with PowerPoint, averaging 10-15 minutes in length.
The event will be pre-recorded and go live May 25 th starting at 9:00 a.m. EST. It will be archived for three months and available with login. The conference pages will be featured for investors at both Investorideas.com and SmallCapvoice.com.
Resource speakers include Mr. Siddharth Rajeev, Of Fundamental Research Corp, Eric Coffin from Hard Rock Analyst, Peter Grandich, Lawrence Roulston and Stephen Whiteside of TheUpTrend.com.
Learn More about the Mining Conference
http://www.investorideas.com/MSS/Conference.asp
Free Investor Sign-Up
http://www.smallcapvoice.com/ii_scv/investor-signup.html
Public Company Sign-Up
http://www.smallcapvoice.com/ii_scv/company-signup.html
Mining Stocks:
Goldcorp (TSX: G, NYSE: GG)
Goldcorp is the fastest growing, lowest-cost senior gold producer with operations and development projects in politically stable jurisdictions throughout the Americas. Our strong project pipeline is positioned to drive long-term, sustainable growth. A Canadian company headquartered in Vancouver, British Columbia, Goldcorp employs more than 11,500 people worldwide. Goldcorp is committed to responsible mining practices and is well-positioned to deliver sustained, industry leading growth and performance. We endeavor to deliver sustainable prosperity for our shareholders, employees, business partners and the communities in which we operate.
Contact
Jeff Wilhoit
VP, Investor Relations
(604) 696-3074
info@goldcorp.com
www.goldcorp.com Trueclaim Exploration Inc. (OTCQX: TRMNF) (TSX-V: TRM)
Trueclaim Exploration Inc. is a mineral exploration company. Trueclaim is engaged in the acquisition and development of precious and base metals properties in strategically located areas, currently within Ontario and Arizona.The Company's current principal project is the former Scadding Gold Mine near Sudbury, Ontario. The Scadding claims are part of approximately 45,000 acres the Company has assembled in this area.
Contact
Jim Elbert
jelbert@trueclaim.ca
www.trueclaimexploration.com
Running Fox (TSX-V: RUN) ( US OTC: RFXRF) ( FRANKFURT: C8Q)
Running Fox is a Canadian growth-oriented resource company with mineral projects including US uranium and Canadian gold properties, oil and gas assets, and oilfield service operations.
Contact
Steven Schurman
Running Fox Resource Corp.
1 604 725 8868
www.foxgold.ca
Yale Resources Ltd. (TSX-V - YLL and Frankfurt - YAB)
Yale Resources Yale Resources Ltd. is an exploration and development company building value utilizing the Project Generator business model. With its Mexican operations based out of Hermosillo, Sonora, Yale is utilizing its extensive Mexican network to identify, acquire and advance projects of merit. Yale's partners are scheduled to spend greater than $1,000,000 on exploration on the Company's properties over the next 12 months.
Contact
Ian Foreman
info@yaleresources.com
www.yaleresources.com
Currie Rose Resources Inc. (TSX.V: CUI) (OTC: CUIRF)
Currie Rose Resources Inc. is a gold exploration company listed on the Toronto Venture Exchange under the symbol CUI-V, Frankfurt Exchange CDV, and U.S. OTC Market symbol CUIRF. The main focus is the Company's gold exploration projects in The Lake Victoria Gold Fields in Tanzania
IR contact
Harold Smith
harold@currierose.com
www.currierose.com
Strategic Resources (TSXV: UVR)
Strategic Resources is a Canadian based junior exploration company with uranium/vanadium exploration projects in Catron County, New Mexico, Rare Earth exploration projects in Lincoln County and Socorro County, New Mexico and a Lithium project in Malheur County, Oregon.
www.strategicresourcesinc.ca
IR Contact
Malcolm Bucholtz
Supercyclereport@gmail.com
Media sponsors include the Streetwise Reports / Gold Report, mining investor sites Mine Snooper www.minesnooper.com , International Mining Research Inc (www.internationalminingresearch.com ) and the investor research magazine, the Opportunist.
About www.InvestorIdeas.com: Investor Ideas that Can Change the World
Investor Ideas is a global financial media online destination specialized in sector investing content including mining and energy stocks.
About SmallCapVoice.com, Inc.: Specializing in Covering Small Cap Stocks & Providing Small Cap Investor Relations
Recognized corporate investor relations firm SmallCapVoice.com, Inc. is known for its ability to help emerging growth companies build a following among retail and institutional investors.
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp
Disclosure: YLL is also a featured showcase stock on Investorideas.com
Learn more: http://www.investorideas.com/About/News/Clientspecifics.asp
For info on presenting as a public company, speaker or media sponsor contact
Cali Van Zant: 800-665-0411 - cvanzant@investorideas.com
Stuart T. Smith CEO
512-267-2430
ssmith@smallcapvoice.com
Source - Investorideas.com, SmallCapVoice.com
May 13, 2011 - www.Investorideas.com and www.SmallCapVoice.com, leaders in small cap investor stock announce publicly trading mining stocks and presenters at this month’s free online investor conference discussing the future of mining stocks. Presenting Mining Stocks Include; (TSX: G, NYSE: GG), (TSX.V: CUI), (TSXV: UVR), (TSX-V: YLL), (TSX-V: RUN) and (TSX-V: TRM).
Mining company, Goldcorp (TSX: G, NYSE: GG)will present as the keynote mining stock at online mining conference, Follow the Money in Mining and Metals, May 25 th and 26.
The online conference is free to investors with login registration. The presentations will be an audio format with PowerPoint, averaging 10-15 minutes in length.
The event will be pre-recorded and go live May 25 th starting at 9:00 a.m. EST. It will be archived for three months and available with login. The conference pages will be featured for investors at both Investorideas.com and SmallCapvoice.com.
Resource speakers include Mr. Siddharth Rajeev, Of Fundamental Research Corp, Eric Coffin from Hard Rock Analyst, Peter Grandich, Lawrence Roulston and Stephen Whiteside of TheUpTrend.com.
Learn More about the Mining Conference
http://www.investorideas.com/MSS/Conference.asp
Free Investor Sign-Up
http://www.smallcapvoice.com/ii_scv/investor-signup.html
Public Company Sign-Up
http://www.smallcapvoice.com/ii_scv/company-signup.html
Mining Stocks:
Goldcorp (TSX: G, NYSE: GG)
Goldcorp is the fastest growing, lowest-cost senior gold producer with operations and development projects in politically stable jurisdictions throughout the Americas. Our strong project pipeline is positioned to drive long-term, sustainable growth. A Canadian company headquartered in Vancouver, British Columbia, Goldcorp employs more than 11,500 people worldwide. Goldcorp is committed to responsible mining practices and is well-positioned to deliver sustained, industry leading growth and performance. We endeavor to deliver sustainable prosperity for our shareholders, employees, business partners and the communities in which we operate.
Contact
Jeff Wilhoit
VP, Investor Relations
(604) 696-3074
info@goldcorp.com
www.goldcorp.com Trueclaim Exploration Inc. (OTCQX: TRMNF) (TSX-V: TRM)
Trueclaim Exploration Inc. is a mineral exploration company. Trueclaim is engaged in the acquisition and development of precious and base metals properties in strategically located areas, currently within Ontario and Arizona.The Company's current principal project is the former Scadding Gold Mine near Sudbury, Ontario. The Scadding claims are part of approximately 45,000 acres the Company has assembled in this area.
Contact
Jim Elbert
jelbert@trueclaim.ca
www.trueclaimexploration.com
Running Fox (TSX-V: RUN) ( US OTC: RFXRF) ( FRANKFURT: C8Q)
Running Fox is a Canadian growth-oriented resource company with mineral projects including US uranium and Canadian gold properties, oil and gas assets, and oilfield service operations.
Contact
Steven Schurman
Running Fox Resource Corp.
1 604 725 8868
www.foxgold.ca
Yale Resources Ltd. (TSX-V - YLL and Frankfurt - YAB)
Yale Resources Yale Resources Ltd. is an exploration and development company building value utilizing the Project Generator business model. With its Mexican operations based out of Hermosillo, Sonora, Yale is utilizing its extensive Mexican network to identify, acquire and advance projects of merit. Yale's partners are scheduled to spend greater than $1,000,000 on exploration on the Company's properties over the next 12 months.
Contact
Ian Foreman
info@yaleresources.com
www.yaleresources.com
Currie Rose Resources Inc. (TSX.V: CUI) (OTC: CUIRF)
Currie Rose Resources Inc. is a gold exploration company listed on the Toronto Venture Exchange under the symbol CUI-V, Frankfurt Exchange CDV, and U.S. OTC Market symbol CUIRF. The main focus is the Company's gold exploration projects in The Lake Victoria Gold Fields in Tanzania
IR contact
Harold Smith
harold@currierose.com
www.currierose.com
Strategic Resources (TSXV: UVR)
Strategic Resources is a Canadian based junior exploration company with uranium/vanadium exploration projects in Catron County, New Mexico, Rare Earth exploration projects in Lincoln County and Socorro County, New Mexico and a Lithium project in Malheur County, Oregon.
www.strategicresourcesinc.ca
IR Contact
Malcolm Bucholtz
Supercyclereport@gmail.com
Media sponsors include the Streetwise Reports / Gold Report, mining investor sites Mine Snooper www.minesnooper.com , International Mining Research Inc (www.internationalminingresearch.com ) and the investor research magazine, the Opportunist.
About www.InvestorIdeas.com: Investor Ideas that Can Change the World
Investor Ideas is a global financial media online destination specialized in sector investing content including mining and energy stocks.
About SmallCapVoice.com, Inc.: Specializing in Covering Small Cap Stocks & Providing Small Cap Investor Relations
Recognized corporate investor relations firm SmallCapVoice.com, Inc. is known for its ability to help emerging growth companies build a following among retail and institutional investors.
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp
Disclosure: YLL is also a featured showcase stock on Investorideas.com
Learn more: http://www.investorideas.com/About/News/Clientspecifics.asp
For info on presenting as a public company, speaker or media sponsor contact
Cali Van Zant: 800-665-0411 - cvanzant@investorideas.com
Stuart T. Smith CEO
512-267-2430
ssmith@smallcapvoice.com
Source - Investorideas.com, SmallCapVoice.com
Gold Stocks to Watch May 13th; (TSX-V: RUN), (AMEX:RIC), (TSX: G), (OTCBB: RNGC)
May 13, 2011 (Investorideas.com Mining Stocks Newswire) - Investorideas.com, a leader in sector stock research including gold and mining stocks reports on trading for May 13 th for Goldcorp, Inc. (TSX: G), Running Fox Resource Corp. (TSX-V: RUN), Richmont Mines, Inc. (AMEX: RIC) and Ranger Gold (OTCBB: RNGC). Gold prices continue to fluctuate with the US dollar, with gold currently trading at $1,490.70 -15.90 -1.06%.
Goldcorp, Inc. (TSX: G) and Running Fox Resource Corp. (TSX-V: RUN) are both presenting in the upcoming Online Mining Conference, Follow the Money in Mining and Metals this May 25 th.
Goldcorp (TSX: G, NYSE: GG)will present as the keynote mining stock .The online conference is free to investors with login registration. The presentations will be an audio format with PowerPoint, averaging 10-15 minutes in length.
The event will be pre-recorded and go live May 25 th starting at 9:00 a.m. EST. It will be archived for three months and available with login. The conference pages will be featured for investors at both Investorideas.com and SmallCapvoice.com.
Sector Snapshot
Trading May 13 th (at time of release)
Running Fox Resource Corp. (TSX-V: RUN)
TSX Gold Stock News; Running Fox (TSX-V: RUN) Reports it Owns 100% or the Brett Gold and Silver Project
"VANCOUVER, BRITISH COLUMBIA - April 6, 2011 (Investorideas.com Mining stocks newswire) - Running Fox Resources, (TSX VENTURE: RUN; PINK SHEETS: RFXRF; FRANKFURT: C8Q) reports the following news and update;
Steven Schurman, P. Geol (US), CEO, Director, reports: Running Fox Resources, (TSX VENTURE: RUN; PINK SHEETS: RFXRF; FRANKFURT: C8Q) is pleased to report that it has completed the acquisition of the remaining 50% of the its high grade Brett Gold Project”
Full News at: http://www.investorideas.com/news/2011/mining/04062.asp
Recent Gold Stocks News: Richmont Mines, Inc. (AMEX: RIC)
Richmont Mines Reports Strong Results in the First Quarter of 2011
"MONTREAL, QUEBEC, CANADA) - Richmont Mines Inc. (TSX: RIC) (AMEX:RIC), ("Richmont" or the "Company") is pleased to announce financial and operational results for its first quarter ended March 31, 2011. Financial results are based on International Financial Reporting Standards ("IFRS") and dollars are reported in Canadian currency, unless otherwise noted.”
Full News at: http://finance.yahoo.com/news/Richmont-Mines-Reports-Strong-iw-112914755.html?x=0&.v=1
Recent Gold Stocks News: RANGER GOLD CORP (OTCBB: RNGC)
Ranger Gold Receiving Bids for Drill Rigs on Its Nevada Properties
"CARSON, CITY, NV- Ranger Gold Corp. (OTCBB: RNGC) is pleased to announce that it has engaged drilling contractors in preparation for drilling on its Nevada holdings.”
Full news at: http://finance.yahoo.com/news/Ranger-Gold-Receiving-Bids-iw-2302198561.html?x=0&.v=1
Mining Conference Links -
Learn More about the Mining Conference - Follow the Money in Mining and Metals http://www.investorideas.com/MSS/Conference.asp
Free Investor Sign-Up
http://www.smallcapvoice.com/ii_scv/investor-signup.html
Public Company Sign-Up
http://www.smallcapvoice.com/ii_scv/company-signup.html
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including energy and mining stocks, in addition to global markets including China, India, the Middle East and Australia. Investorideas.com is known for its comprehensive stock directories in each sector and sector specific newswires.
Sign up for the free investor news letter and get stock alerts in leading sectors! http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure: The following news is paid for and /or published as information only for our readers. Running Fox Resource Corp. (TSX.V: RUN) for month of press release services (one thousand five hundred) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of principal .This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
For Additional Information about Investorideas.com energy portals: 800-665-0411 or cvanzant@investorideas.com
May 13, 2011 (Investorideas.com Mining Stocks Newswire) - Investorideas.com, a leader in sector stock research including gold and mining stocks reports on trading for May 13 th for Goldcorp, Inc. (TSX: G), Running Fox Resource Corp. (TSX-V: RUN), Richmont Mines, Inc. (AMEX: RIC) and Ranger Gold (OTCBB: RNGC). Gold prices continue to fluctuate with the US dollar, with gold currently trading at $1,490.70 -15.90 -1.06%.
Goldcorp, Inc. (TSX: G) and Running Fox Resource Corp. (TSX-V: RUN) are both presenting in the upcoming Online Mining Conference, Follow the Money in Mining and Metals this May 25 th.
Goldcorp (TSX: G, NYSE: GG)will present as the keynote mining stock .The online conference is free to investors with login registration. The presentations will be an audio format with PowerPoint, averaging 10-15 minutes in length.
The event will be pre-recorded and go live May 25 th starting at 9:00 a.m. EST. It will be archived for three months and available with login. The conference pages will be featured for investors at both Investorideas.com and SmallCapvoice.com.
Sector Snapshot
Trading May 13 th (at time of release)
- Goldcorp, Inc. (TSX: G) trading at $ 45.99, up 0.81 (0.39%) on over 2 million shares of volume
- Running Fox Resource Corp. (TSX-V: RUN) trading at $0.25 up 0.01, (4.17%)
- Richmont Mines, Inc. (AMEX: RIC) trading at $7.85, up 0.45 (6.08%) on over 400, 000 shares in volume
- RANGER GOLD CORP (OTCBB: RNGC) trading at $01.07, up 0.03 (2.88%) on over 200,000 shares in volume
Running Fox Resource Corp. (TSX-V: RUN)
TSX Gold Stock News; Running Fox (TSX-V: RUN) Reports it Owns 100% or the Brett Gold and Silver Project
"VANCOUVER, BRITISH COLUMBIA - April 6, 2011 (Investorideas.com Mining stocks newswire) - Running Fox Resources, (TSX VENTURE: RUN; PINK SHEETS: RFXRF; FRANKFURT: C8Q) reports the following news and update;
Steven Schurman, P. Geol (US), CEO, Director, reports: Running Fox Resources, (TSX VENTURE: RUN; PINK SHEETS: RFXRF; FRANKFURT: C8Q) is pleased to report that it has completed the acquisition of the remaining 50% of the its high grade Brett Gold Project”
Full News at: http://www.investorideas.com/news/2011/mining/04062.asp
Recent Gold Stocks News: Richmont Mines, Inc. (AMEX: RIC)
Richmont Mines Reports Strong Results in the First Quarter of 2011
"MONTREAL, QUEBEC, CANADA) - Richmont Mines Inc. (TSX: RIC) (AMEX:RIC), ("Richmont" or the "Company") is pleased to announce financial and operational results for its first quarter ended March 31, 2011. Financial results are based on International Financial Reporting Standards ("IFRS") and dollars are reported in Canadian currency, unless otherwise noted.”
Full News at: http://finance.yahoo.com/news/Richmont-Mines-Reports-Strong-iw-112914755.html?x=0&.v=1
Recent Gold Stocks News: RANGER GOLD CORP (OTCBB: RNGC)
Ranger Gold Receiving Bids for Drill Rigs on Its Nevada Properties
"CARSON, CITY, NV- Ranger Gold Corp. (OTCBB: RNGC) is pleased to announce that it has engaged drilling contractors in preparation for drilling on its Nevada holdings.”
Full news at: http://finance.yahoo.com/news/Ranger-Gold-Receiving-Bids-iw-2302198561.html?x=0&.v=1
Mining Conference Links -
Learn More about the Mining Conference - Follow the Money in Mining and Metals http://www.investorideas.com/MSS/Conference.asp
Free Investor Sign-Up
http://www.smallcapvoice.com/ii_scv/investor-signup.html
Public Company Sign-Up
http://www.smallcapvoice.com/ii_scv/company-signup.html
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including energy and mining stocks, in addition to global markets including China, India, the Middle East and Australia. Investorideas.com is known for its comprehensive stock directories in each sector and sector specific newswires.
Sign up for the free investor news letter and get stock alerts in leading sectors! http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure: The following news is paid for and /or published as information only for our readers. Running Fox Resource Corp. (TSX.V: RUN) for month of press release services (one thousand five hundred) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of principal .This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
For Additional Information about Investorideas.com energy portals: 800-665-0411 or cvanzant@investorideas.com
POINT
Discover Financial Services (NYSE:DFS) announced after the closing bell Thursday that it has reached a definitive agreement to acquire substantially all of the operating and related assets of Home Loan Center, a subsidiary of Tree.com, Inc. (NASDAQ:TREE) for approximately $55.9 million, adding a residential mortgage component to Discover’s direct-to-consumer banking business.
Trading Close-Up
- Tree.com, Inc. (NasdaqGM: TREE) trading at $6.51, up 1.11 (20.56%) 12:59PM EDT
- Tranzyme, Inc. (NasdaqGM: TZYM) trading at $4.74, up 0.68 (16.75%) 1:17PM EDT
- Gulf Resources, Inc. (NasdaqGS: GFRE) trading at $3.14, up 0.44 (16.30%) 1:20PM EDT
- Vermillion, Inc. (NasdaqGM: VRML) trading at $ 6.44, up 0.61 (10.46%) 1:25PM EDT
Tree.com, Inc. (NASDAQ:TREE is the parent of several brands and businesses that provide information, tools, advice, products and services for critical transactions in our customers' lives. Tree.com, Inc. is the parent company of wholly owned operating subsidiaries: LendingTree, LLC and Home Loan Center, Inc., which does business as LendingTree Loans. Our family of brands includes: LendingTree.com®, LendingTree Loans, GetSmart.com®, RealEstate.com®, DegreeTree.com, HealthTree.com, LendingTreeAutos.com, DoneRight.com, and InsuranceTree.com. These brands serve as an ally for consumers who are looking to comparison shop for loans, real estate and other services from multiple businesses and professionals who will compete for their business.
Tree.com, Inc. is headquartered in Charlotte, N.C. and maintains operations solely in the United States. For more information, please visit www.tree.com.
Investorideas.com Free Investor Tools;
Sign up for the free investor news letter and get stock alerts in leading sectors! http://www.investorideas.com/Resources/Newsletter.asp
Free Online Investor Conference- Mining and Metal Stocks
Register free - http://www.smallcapvoice.com/ii_scv/investor-signup.html
Join Investor Ideas - Research energy stocks, mining, agriculture stocks, cloud computing stocks and more…
Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only eleven stock directories in leading sectors including renewable energy, water and energy stocks.
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
About InvestorIdeas.com:
Investor Ideas is a global financial media online destination specialized in sector investing content. Investor Ideas (and portals within the hub) was one of the first online investing and business resources providing in-depth information, news and stock directories in renewable energy, homeland security and water sectors. InvestorIdeas.com features over twenty industry sectors and global markets including China, India, Middle East and Australia.
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
For Additional Information and or interest in becoming a content /revenue partner:
Dawn Van Zant: 800-665-0411 - dvanzant@investorideas.com
Source - Investorideas.com
Biotech/Pharma Stocks: (OTCBB: AEMD), (NYSE: MRK), (VRTX) Progress on Potential New Treatments for Hepatitis C Virus (HCV)
Point Roberts, WA - May 13 2011 - Investorideas.com. a leader in sector stock research including biotech and pharma stocks issues a sector snapshot of three companies, Aethlon Medical, Inc. (OTCBB: AEMD), Vertex Pharmaceuticals Inc. (VRTX), Merck & Company, Inc. (NYSE: MRK) and their developments and progress for the treatment of Hepatitis C Virus (HCV).
Trading Snapshot
Full News: http://www.investorideas.com/CO/AEMD/news/2011/05091.asp
Vertex Pharmaceuticals Inc (VRTX ) reported in its May 3 rd update that they intend to use the name INCIVEK (in-SEE-veck) as the trade name for telaprevir. If approved, telaprevir will be marketed by Vertex as INCIVEK in the U.S. Vertex recently completed its FDA Antiviral Drugs Advisory Committee meeting for INCIVEK (telaprevir). At the conclusion of the meeting, the committee voted unanimously (18-0) to recommend FDA approval of INCIVEK (telaprevir) for people with genotype 1 chronic hepatitis C who were not treated previously and those who were treated previously but not cured with currently available medicines. Vertex expects the FDA to provide its formal decision on the New Drug Application for INCIVEK (telaprevir) by May 23.
Full news: http://finance.yahoo.com/news/Vertex-Reports-First-Quarter-bw-1531348977.html?x=0&.v=1
Merck & Company, Inc.(NYSE: MRK ) reported April 27 th, that the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted unanimously that the available data support approval of Merck's investigational medicine VICTRELIS™ (boceprevir) for the treatment of patients with chronic hepatitis C virus (HCV) genotype 1 infection in combination with current standard therapy. VICTRELIS is one of a new class of medicines known as HCV protease inhibitors being evaluated by the FDA for the treatment of chronic HCV genotype 1 infection in adult patients with compensated liver disease who are previously untreated or who have failed previous therapy.
The committee's recommendation will be considered by the FDA in its review of the New Drug Application for VICTRELIS. The FDA is not bound by the committee's guidance, but takes its advice into consideration when reviewing investigational medicines. The company anticipates FDA action on VICTRELIS by mid-May.
Full news: http://www.merck.com/newsroom/news-release-archive/research-and-development/2011_0427.html
Structure of the IRES located in the 5'-UTR of HCV
http://en.wikipedia.org/wiki/Hepatitis_C_virus
Company Snapshot
About Aethlon Medical (OTCBB: AEMD)
Visit the showcase page on Investorideas.com
http://www.investorideas.com/CO/AEMD
Get added to the company's news alerts:
http://www.investorideas.com/Resources/Newsletter.asp
At Aethlon Medical, we create revolutionary devices to address infectious disease and cancer. Our devices are designed to be novel platform solutions that fill therapeutic voids or aid in disease diagnosis and monitoring.
Our Hemopurifier® is the first medical device to selectively target the removal of infectious viruses and immunosuppressive proteins from the entire circulatory system. We recently discovered that our Hemopurifier® captures tumor-secreted exosomes that suppress the immune system of those afflicted with cancer. Prior to this discovery, a therapeutic strategy to directly inhibit or reverse the immunosuppressive destruction caused by exosomes did not exist in cancer care. By eliminating this mechanism, we believe our Hemopurifier® can fill an unmet clinical need and provide the benefit of an immune-based therapy without adding drug toxicity or interaction risks to established and emerging treatment strategies.
Human studies have documented the ability of our Hemopurifier® to safely reduce viral load in both Hepatitis-C virus (HCV) and Human Immunodeficiency Virus (HIV) infected patients without the administration of antiviral drugs. However, our initial clinical and commercialization focus is to establish our Hemopurifier® as an adjunct therapy to enhance the benefit of both infectious disease and cancer treatment regimens. In this regard, we plan to commercialize our Hemopurifier® in India as we advance our clinical strategies in the United States and the European Union. In vitro studies conducted by government and non-government research institutes have also verified that our Hemopurifier® has broad-spectrum capabilities against bioterror and emerging pandemic threats. These studies have confirmed the capture of Dengue Hemorrhagic Virus, Ebola Hemorrhagic Virus, Lassa Hemorrhagic Virus, West Nile Virus, H5N1 Avian Influenza Virus, 2009 H1N1 Influenza Virus, the reconstructed Spanish Flu of 1918 Virus, and Monkeypox Virus, which serves as a model for human Smallpox infection.
As a therapeutic device, the Hemopurifier® provides us with a pipeline into four significant market opportunities:
1.Cancer: A treatment candidate to improve patient responsiveness to established cancer therapies by removing immunosuppressive exosomes from circulation.
2.Hepatitis-C Virus (HCV): As an adjunct therapy to accelerate viral load reduction at the outset of standard of care drug regimens.
3.Human Immunodeficiency Virus (HIV): Provides a potential therapeutic option for HIV-infected individuals to manage disease progression once they become resistant to antiviral drug regimens.
4.Bioterror and Pandemic Threats: Represents the most advanced broad-spectrum strategy to address untreatable bioterror and emerging pandemic threats.
The Hemopurifier® is an expansive multi-patented platform technology whose mechanism of action can be leveraged to provide therapeutic, diagnostic, and biomarker discovery solutions. As a therapeutic, the Hemopurifier® is a single-use disposable cartridge designed for implementation within the established infrastructure of dialysis machines and other blood circulatory pumps already located in hospitals and clinics worldwide.
In design, our Hemopurifier® is a selective filtration device containing affinity agents that tightly bind to high-mannose structures unique to the surface of exosomes produced by cancer and glycoproteins residing on the envelope of viruses. These agents are immobilized around approximately 2800 porous hollow fibers that run the interior length of our device. The resulting design provides us the novel ability to separate both exosome and viral targets away from blood cells so they can then be selectively and permanently removed from the circulatory system. In application, blood circulation is established into the Hemopurifier® via a catheter or other blood access device. Once blood flow has been established, treatment benefit is immediate as the entire circulatory system can pass through the Hemopurifier® in as little as 15 minutes.
Our wholly owned subsidiary, Exosome Sciences, Inc. (ESI) is focused on the development of exosome-targeted products and services that improve cancer diagnosis, provide post-treatment cancer surveillance, and aid in the discovery of biomarkers that allow doctors to optimize patient therapy. Additional information regarding Aethlon Medical and Exosome Sciences can be accessed online at www.aethlonmedical.com.
Contact:
James A. Joyce
Chairman, CEO
858.459.7800 x301
jj@aethlonmedical.com
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, including biotech stocks with its portal BiotechIndustryStocks.com.
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. AETHLON MEDICAL INC(OTC BB: AEMD ) Showcase biotech, biodefense and defense stock on Investorideas.com ( $one thousand five hundred per month, $five thousand per month in 144 stock)Effective March 15, 2011
800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com
Point Roberts, WA - May 13 2011 - Investorideas.com. a leader in sector stock research including biotech and pharma stocks issues a sector snapshot of three companies, Aethlon Medical, Inc. (OTCBB: AEMD), Vertex Pharmaceuticals Inc. (VRTX), Merck & Company, Inc. (NYSE: MRK) and their developments and progress for the treatment of Hepatitis C Virus (HCV).
Trading Snapshot
- Aethlon Medical, Inc. (OTCBB: AEMD) trading at $0.1030, up 0.0040 (4.04%)
- Merck & Company, Inc. (NYSE: MRK ) trading at$37.08, down 0.12 (0.32%)
- Vertex Pharmaceuticals Inc (VRTX ) trading at $57.30, down 0.71 (1.22%)
Full News: http://www.investorideas.com/CO/AEMD/news/2011/05091.asp
Vertex Pharmaceuticals Inc (VRTX ) reported in its May 3 rd update that they intend to use the name INCIVEK (in-SEE-veck) as the trade name for telaprevir. If approved, telaprevir will be marketed by Vertex as INCIVEK in the U.S. Vertex recently completed its FDA Antiviral Drugs Advisory Committee meeting for INCIVEK (telaprevir). At the conclusion of the meeting, the committee voted unanimously (18-0) to recommend FDA approval of INCIVEK (telaprevir) for people with genotype 1 chronic hepatitis C who were not treated previously and those who were treated previously but not cured with currently available medicines. Vertex expects the FDA to provide its formal decision on the New Drug Application for INCIVEK (telaprevir) by May 23.
Full news: http://finance.yahoo.com/news/Vertex-Reports-First-Quarter-bw-1531348977.html?x=0&.v=1
Merck & Company, Inc.(NYSE: MRK ) reported April 27 th, that the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted unanimously that the available data support approval of Merck's investigational medicine VICTRELIS™ (boceprevir) for the treatment of patients with chronic hepatitis C virus (HCV) genotype 1 infection in combination with current standard therapy. VICTRELIS is one of a new class of medicines known as HCV protease inhibitors being evaluated by the FDA for the treatment of chronic HCV genotype 1 infection in adult patients with compensated liver disease who are previously untreated or who have failed previous therapy.
The committee's recommendation will be considered by the FDA in its review of the New Drug Application for VICTRELIS. The FDA is not bound by the committee's guidance, but takes its advice into consideration when reviewing investigational medicines. The company anticipates FDA action on VICTRELIS by mid-May.
Full news: http://www.merck.com/newsroom/news-release-archive/research-and-development/2011_0427.html
Structure of the IRES located in the 5'-UTR of HCV http://en.wikipedia.org/wiki/Hepatitis_C_virus
Company Snapshot
About Aethlon Medical (OTCBB: AEMD)
Visit the showcase page on Investorideas.com
http://www.investorideas.com/CO/AEMD
Get added to the company's news alerts:
http://www.investorideas.com/Resources/Newsletter.asp
At Aethlon Medical, we create revolutionary devices to address infectious disease and cancer. Our devices are designed to be novel platform solutions that fill therapeutic voids or aid in disease diagnosis and monitoring.
Our Hemopurifier® is the first medical device to selectively target the removal of infectious viruses and immunosuppressive proteins from the entire circulatory system. We recently discovered that our Hemopurifier® captures tumor-secreted exosomes that suppress the immune system of those afflicted with cancer. Prior to this discovery, a therapeutic strategy to directly inhibit or reverse the immunosuppressive destruction caused by exosomes did not exist in cancer care. By eliminating this mechanism, we believe our Hemopurifier® can fill an unmet clinical need and provide the benefit of an immune-based therapy without adding drug toxicity or interaction risks to established and emerging treatment strategies.
Human studies have documented the ability of our Hemopurifier® to safely reduce viral load in both Hepatitis-C virus (HCV) and Human Immunodeficiency Virus (HIV) infected patients without the administration of antiviral drugs. However, our initial clinical and commercialization focus is to establish our Hemopurifier® as an adjunct therapy to enhance the benefit of both infectious disease and cancer treatment regimens. In this regard, we plan to commercialize our Hemopurifier® in India as we advance our clinical strategies in the United States and the European Union. In vitro studies conducted by government and non-government research institutes have also verified that our Hemopurifier® has broad-spectrum capabilities against bioterror and emerging pandemic threats. These studies have confirmed the capture of Dengue Hemorrhagic Virus, Ebola Hemorrhagic Virus, Lassa Hemorrhagic Virus, West Nile Virus, H5N1 Avian Influenza Virus, 2009 H1N1 Influenza Virus, the reconstructed Spanish Flu of 1918 Virus, and Monkeypox Virus, which serves as a model for human Smallpox infection.
As a therapeutic device, the Hemopurifier® provides us with a pipeline into four significant market opportunities:
1.Cancer: A treatment candidate to improve patient responsiveness to established cancer therapies by removing immunosuppressive exosomes from circulation.
2.Hepatitis-C Virus (HCV): As an adjunct therapy to accelerate viral load reduction at the outset of standard of care drug regimens.
3.Human Immunodeficiency Virus (HIV): Provides a potential therapeutic option for HIV-infected individuals to manage disease progression once they become resistant to antiviral drug regimens.
4.Bioterror and Pandemic Threats: Represents the most advanced broad-spectrum strategy to address untreatable bioterror and emerging pandemic threats.
The Hemopurifier® is an expansive multi-patented platform technology whose mechanism of action can be leveraged to provide therapeutic, diagnostic, and biomarker discovery solutions. As a therapeutic, the Hemopurifier® is a single-use disposable cartridge designed for implementation within the established infrastructure of dialysis machines and other blood circulatory pumps already located in hospitals and clinics worldwide.
In design, our Hemopurifier® is a selective filtration device containing affinity agents that tightly bind to high-mannose structures unique to the surface of exosomes produced by cancer and glycoproteins residing on the envelope of viruses. These agents are immobilized around approximately 2800 porous hollow fibers that run the interior length of our device. The resulting design provides us the novel ability to separate both exosome and viral targets away from blood cells so they can then be selectively and permanently removed from the circulatory system. In application, blood circulation is established into the Hemopurifier® via a catheter or other blood access device. Once blood flow has been established, treatment benefit is immediate as the entire circulatory system can pass through the Hemopurifier® in as little as 15 minutes.
Our wholly owned subsidiary, Exosome Sciences, Inc. (ESI) is focused on the development of exosome-targeted products and services that improve cancer diagnosis, provide post-treatment cancer surveillance, and aid in the discovery of biomarkers that allow doctors to optimize patient therapy. Additional information regarding Aethlon Medical and Exosome Sciences can be accessed online at www.aethlonmedical.com.
Contact:
James A. Joyce
Chairman, CEO
858.459.7800 x301
jj@aethlonmedical.com
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, including biotech stocks with its portal BiotechIndustryStocks.com.
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. AETHLON MEDICAL INC(OTC BB: AEMD ) Showcase biotech, biodefense and defense stock on Investorideas.com ( $one thousand five hundred per month, $five thousand per month in 144 stock)Effective March 15, 2011
800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com
Wind Stocks Investor Trading Alert; Broadwind Energy (NasdaqGS: BWEN), Clean Wind Energy Tower, (OTCBB: CWET), Catch the Wind (TSX-V: CTW), Vestas (Copenhagen: VWS.CO)
According to the company release. "The sharp increase reflects significant improvement in demand and increased production compared to a very weak prior year quarter. Sales in both the Towers and Gearing segments were up substantially compared to the prior year as a result of the increased demand, as well as success at rebuilding sales to industrial customers.
Wind Stocks
- Broadwind Energy, Inc. (NasdaqGS: BWEN ) trading at $1.56, up [0.03 (1.96%)
- Catch the Wind Ltd. (TSX-V: CTW) trading up at$ 0.57, up 0.01 (1.79%)
- China Ming Yang Wind Power Group (NYSE: MY ) trading at $7.81, down 0.22 (2.74%)
- Clean Wind Energy Tower, Inc. (OTCBB: CWET) trading at $0.32
- Vestas Wind Systems (Copenhagen: VWS.CO ) trading up at $56.40, up 0.20 (0.13%)
Clean Wind Energy Tower (OTCBB: CWET) Files "Atmospheric Energy Extraction Devices & Methods" Patent for Wind Tower
ANNAPOLIS, MD - May 5, 2011 (InvestorIdeas.com Newswire) - Clean Wind Energy Tower, Inc. (OTCBB: CWET), a clean energy company developing Downdraft Towers, reports it has filed with the United States Patent & Trademark Office "A Petition to Make Special Under the Accelerated Examination Program," a patent application titled Atmospheric Energy Extraction Devices and Methods.
The application covers the addition of specific external design components, physical structure and systems that both substantially enhances structural integrity of the tower and captures wind directly striking the external vertical surfaces of the downdraft tower from any direction, beyond those winds already induced into the internal tube of the tower, and also enhances slow moving air to create downburst winds, substantially increasing total power generation of a single tower unit.
Full news:http://www.investorideas.com/CO/CWE/news/2011/05051.asp
Broadwind Energy, Inc. Announces First Quarter 2011 Results
Highlights:
- Net sales of $43.5 million, double the prior year quarter
- Order intake up 150%; ending backlog strong at $227 million
- Adjusted EBITDA increases to $0.1 million vs. a $7.2 million loss in Q1 2010
- Sale of Logistics business completed on March 4, 2011
- At March 31, 2011, cash and marketable securities rose to $22.0 million
CATCH THE WIND SIGNS SALES AGREEMENT WITH TRANSALTA FOR 20 VINDICATOR® LWS UNITS
- Represents Catch the Wind's largest sales order to date -
MANASSAS, VA, May 12 /CNW/ - Catch the Wind Ltd. (TSX-V: CTW) announced today that it has sold 20 Vindicator® Laser Wind Sensor (LWS) units to TransAlta Corporation, Canada's largest independent renewable energy provider, with an option to purchase additional units. The sale is Catch the Wind's largest to date for wind turbine control.
Full news:http://www.newswire.ca/en/releases/archive/May2011/12/c3986.html
Vestas receives 80 MW order in Brazil
Vestas has received a firm and unconditional order for 80 MW to Brazil
Full news:http://www.vestas.com/en/investor/announcements/company-announcements/news-display.aspx?action=3&NewsID=2667
Research more wind stocks with the renewable energy stocks directory:
http://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp
Wind Company Snapshot
Clean Wind Energy Tower, Inc. (OTCBB: CWET) was established to commercialize a number of proven and validated technologies and construction systems into a single large downdraft tower structure that produces abundant inexpensive electricity.
www.cleanwindenergytower.com
Visit the CWET showcase page at Investorideas.com : http://www.investorideas.com/CO/CWE/
About Investorideas.com and our Green Investor content:
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Sign up at Investor Ideas for free investor alerts including news on (OTCBB: CWET)
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure : The following news is part of the Clean Wind Energy Tower, Inc. (OTCBB: CWET) advertising program with Investorideas.com. Clean Wind Energy, Inc. compensates investorideas.com (one thousand five hundred per month, 100,000 144 shares) to be showcased as a renewable energy stock within its hub of sites and blogs.Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com.
Learn more: www.InvestorIdeas.com/About/Disclaimer.asp
For more information about Investorideas.com contact:
800.665.0411, Email: dvanzant@investorideas.com or cvanzant@investorideas.com
Biotech Investor Trading Alert; BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) Trades up 9.01 % on over 5 Million Shares Volume
Point Roberts, WA, LINCOLNSHIRE, Ill - May 13, 2011 – Investorideas.com, a leader in sector stock research for independent investors, issues a trading alert for specialty biotech/pharma stock, BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX). The stock closed trading May 12th, at $2.54, up $ 0.21 (9.01%) on over 5 Million shares and continued gains in after hours trading, up another $0.03, (1.18%).
About BioSante Pharmaceuticals, Inc: BioSante (NASDAQ: BPAX) is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel ® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment. BioSante's first FDA-approved product is Elestrin™ (estradiol gel) indicated for the treatment of hot flashes associated with menopause, marketed in the U.S. by Azur Pharma, BioSante's licensee. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other BioSante products are Bio-T-Gel™, a testosterone gel for male hypogonadism, for which an NDA is pending with a PDUFA date of November 14, 2011, licensed to Teva Pharmaceuticals, and an oral contraceptive in Phase II clinical development using BioSante patented technology. Additional information is available online at: www.biosantepharma.com.
This article may contain forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include statements about BioSante’s plans, objectives, expectations and intentions with respect to future operations and products, future market acceptance, size and potential of LibiGel and other statements identified by words such as “will,” “potential,” “could,” “would,” “can,” “believe,” “intends,” “continue,” “plans,” “expects,” “anticipates,” “estimates,” “may,” other words of similar meaning or the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause BioSante’s actual results to be materially different than those expressed in or implied by BioSante’s forward-looking statements. For BioSante, particular uncertainties and risks include, among others, the difficulty of developing pharmaceutical products, obtaining regulatory and other approvals and achieving market acceptance; the marketing success of BioSante’s licensees or sublicensees; the success of clinical testing; and BioSante’s need for and ability to obtain additional financing. More detailed information on these and additional factors that could affect BioSante’s actual results are described in BioSante’s filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q. All forward-looking statements in this presentation speak only as of the date of this presentation. BioSante undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Contact BioSante:
For info about BioSante Pharmaceuticals, Inc
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953
tswanson@troutgroup.com
For Media:
McKinney/Chicago
Alan Zachary
(312) 506-5220
azachary@mckinneychicago.com
BioSante Pharmaceuticals, Inc: (NASDAQ: BPAX) is a featured showcase biotech/pharma stock on Investorideas.com
The full BPAX company profile is available at http://www.investorideas.com/CO/BPAX/ for interested biotech investors.
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including biotech and pharma stocks. Investorideas.com is known for its comprehensive stock directories in each sector and sector specific newswires.
Disclaimer: The following news/content is paid for as part of the BPAX showcase program (two thousand per month) Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Source: Investorideas.com, BioSante, Investorideas.com
Contact Investorideas.com
800 665 0411 cvanzant@investorideas.com
Point Roberts, WA, LINCOLNSHIRE, Ill - May 13, 2011 – Investorideas.com, a leader in sector stock research for independent investors, issues a trading alert for specialty biotech/pharma stock, BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX). The stock closed trading May 12th, at $2.54, up $ 0.21 (9.01%) on over 5 Million shares and continued gains in after hours trading, up another $0.03, (1.18%).
About BioSante Pharmaceuticals, Inc: BioSante (NASDAQ: BPAX) is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel ® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment. BioSante's first FDA-approved product is Elestrin™ (estradiol gel) indicated for the treatment of hot flashes associated with menopause, marketed in the U.S. by Azur Pharma, BioSante's licensee. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other BioSante products are Bio-T-Gel™, a testosterone gel for male hypogonadism, for which an NDA is pending with a PDUFA date of November 14, 2011, licensed to Teva Pharmaceuticals, and an oral contraceptive in Phase II clinical development using BioSante patented technology. Additional information is available online at: www.biosantepharma.com.This article may contain forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include statements about BioSante’s plans, objectives, expectations and intentions with respect to future operations and products, future market acceptance, size and potential of LibiGel and other statements identified by words such as “will,” “potential,” “could,” “would,” “can,” “believe,” “intends,” “continue,” “plans,” “expects,” “anticipates,” “estimates,” “may,” other words of similar meaning or the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause BioSante’s actual results to be materially different than those expressed in or implied by BioSante’s forward-looking statements. For BioSante, particular uncertainties and risks include, among others, the difficulty of developing pharmaceutical products, obtaining regulatory and other approvals and achieving market acceptance; the marketing success of BioSante’s licensees or sublicensees; the success of clinical testing; and BioSante’s need for and ability to obtain additional financing. More detailed information on these and additional factors that could affect BioSante’s actual results are described in BioSante’s filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q. All forward-looking statements in this presentation speak only as of the date of this presentation. BioSante undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Contact BioSante:
For info about BioSante Pharmaceuticals, Inc
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953
tswanson@troutgroup.com
For Media:
McKinney/Chicago
Alan Zachary
(312) 506-5220
azachary@mckinneychicago.com
BioSante Pharmaceuticals, Inc: (NASDAQ: BPAX) is a featured showcase biotech/pharma stock on Investorideas.com
The full BPAX company profile is available at http://www.investorideas.com/CO/BPAX/ for interested biotech investors.
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including biotech and pharma stocks. Investorideas.com is known for its comprehensive stock directories in each sector and sector specific newswires.
Disclaimer: The following news/content is paid for as part of the BPAX showcase program (two thousand per month) Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Source: Investorideas.com, BioSante, Investorideas.com
Contact Investorideas.com
800 665 0411 cvanzant@investorideas.com
Thursday, May 12, 2011
There is still time to be Part of this May’s Free Online Mining
Conference
Mining Stocks; Added Bonus Get Free News Distribution on
Mining Stocks Newswire
www.Investorideas.com and www.SmallCapVoice.com, leaders in small cap investor research
announce Goldcorp (TSX: G, NYSE: GG) will present as the keynote mining stock at this
month’s online mining investor conference. The online conference is free to investors with login.
Presenting Mining Stocks Include; (TSX: G, NYSE: GG), (TSX.V: CUI),
(TSXV: UVR), (TSX-V – YLL), (TSX-V: RUN), (TSX-V: TRM).
Industry speakers include Mr. Siddharth Rajeev, Of Fundamental Research Corp, Eric Coffin
from Hard Rock Analyst, Peter Grandich, Lawrence Roulston and Stephen Whiteside of
TheUpTrend.com.
The online mining conference, Follow the Money in Mining and Metals, will be held May 25th
and 26. The online conference is free to investors with login registration.
Mining Companies Presenting Receive the following:
■10-20 minute presentation pre-recorded at your convenience on the phone
■Copy of the completed presentation to add to your site
■Be visible on Investorideas.com and SmallCapVoice.com
■Inclusion in press releases, marketing material up to the date of the
conference
■Archived 90 days after
■All that for a one time fee of $1500
Added bonus- Free news release distribution at Investorideas.com Mining
Stocks Newswire ($75 value)
Learn More about the Mining Conference
http://www.investorideas.com/MSS/Conference.asp
Free Investor Sign-Up
http://www.smallcapvoice.com/ii_scv/investor-signup.html
Public Company Sign-Up
http://www.smallcapvoice.com/ii_scv/company-signup.html
- sign up and pay online
For info on presenting as a public company, speaker or media sponsor contact
Cali Van Zant: 800-665-0411 - cvanzant@investorideas.com
Stuart T. Smith CEO
512-267-2430
ssmith@smallcapvoice.com
Source – Investorideas.com, SmallCapVoice.com
Conference
Mining Stocks; Added Bonus Get Free News Distribution on
Mining Stocks Newswire
www.Investorideas.com and www.SmallCapVoice.com, leaders in small cap investor research
announce Goldcorp (TSX: G, NYSE: GG) will present as the keynote mining stock at this
month’s online mining investor conference. The online conference is free to investors with login.
Presenting Mining Stocks Include; (TSX: G, NYSE: GG), (TSX.V: CUI),
(TSXV: UVR), (TSX-V – YLL), (TSX-V: RUN), (TSX-V: TRM).
Industry speakers include Mr. Siddharth Rajeev, Of Fundamental Research Corp, Eric Coffin
from Hard Rock Analyst, Peter Grandich, Lawrence Roulston and Stephen Whiteside of
TheUpTrend.com.
The online mining conference, Follow the Money in Mining and Metals, will be held May 25th
and 26. The online conference is free to investors with login registration.
Mining Companies Presenting Receive the following:
■10-20 minute presentation pre-recorded at your convenience on the phone
■Copy of the completed presentation to add to your site
■Be visible on Investorideas.com and SmallCapVoice.com
■Inclusion in press releases, marketing material up to the date of the
conference
■Archived 90 days after
■All that for a one time fee of $1500
Added bonus- Free news release distribution at Investorideas.com Mining
Stocks Newswire ($75 value)
Learn More about the Mining Conference
http://www.investorideas.com/MSS/Conference.asp
Free Investor Sign-Up
http://www.smallcapvoice.com/ii_scv/investor-signup.html
Public Company Sign-Up
http://www.smallcapvoice.com/ii_scv/company-signup.html
- sign up and pay online
For info on presenting as a public company, speaker or media sponsor contact
Cali Van Zant: 800-665-0411 - cvanzant@investorideas.com
Stuart T. Smith CEO
512-267-2430
ssmith@smallcapvoice.com
Source – Investorideas.com, SmallCapVoice.com
Electric Car Stocks Trading Alert; (AONE), (TSLA), (QTWW), (EVCA)
Quantum Fuel Systems Technologi (NasdaqGM: QTWW) Trading up over 13%, With High of $5.45May 12, 2011 (Investorideas.com renewable energy/green newswire) Investorideas.com a leader in cleantech investor research, reports on green car stocks trading for May 12th. Quantum Fuel Systems Technologi (NasdaqGM: QTWW) is one of the top gainers on the NASDAQ, trading up at $5.13, up 0.62 (13.75%) 12:15PM EDT with a high of $5.45.
Green Car Stocks Sector Snapshot
- A123 Systems, Inc. (NasdaqGM: AONE) trading at $ 6.09, up 0.07 (1.16%) 12:17PM EDT
- EVCARCO (OTCBB: EVCA)) trading at $ 0.0141 - 0.0170
- Tesla Motors, Inc. (NASDAQ: TSLA) trading at $27.33, up 0.26 (0.96%) 12:08PM EDT
- Quantum Fuel Systems Technologi (NasdaqGM: QTWW ) trading at $5.13, up 0.62 (13.75%) 12:15PM EDT
- Dow 12,605.29 -24.74 -0.20%
- Nasdaq 2,846.82 +1.76 +0.06%
- S&P 500 1,340.08 -2.00 -0.15%
- 10 Yr Bond (%) 3.2020% +0.0450
- Oil 97.96 -0.25 -0.25%
- Gold 1,484.80 -5.10 -0.34%
Quantum Previews New Plug-In Hybrid F150 Pickup Truck at the Alternative Clean Transportation (ACT) Expo in Long Beach
IRVINE , Calif. , May 6, 2011- Quantum Fuel Systems Technologies Worldwide, Inc. (Nasdaq:QTWW - News) announced today that it has launched a new line of hybrid vehicles. Quantum has developed a new Plug-in Hybrid Version of the highest volume selling vehicle in America, the Ford F150 Pickup Truck, and will be providing them directly to fleet customers.
Quantum's plug-in hybrid version of the F150 was specifically designed for the demanding use of America's largest fleet operators. The vehicle will be capable of matching the performance of the conventional F150 vehicle while achieving substantially higher fuel economy and producing lower emissions. The PHEV F150 uses Quantum's new "F-Drive" hybrid system which will have a 35 mile electric range before shifting to a hybrid mode where it can continue for a total range of over 400 miles. The Quantum "F-Drive" hybrid system is available in 2WD and 4WD versions. To meet the requirements of fleet customers, the F-Drive has been integrated in the F150 vehicle such that there is no impingement into the cab or bed and it maintains full ground clearance.
Company Snapshot
EVCARCO (OTC.BB: EVCA) - Green, Electric Cars and Natural Gas Vehicles
EVCARCO (OTC.BB:EVCA) (www.evcarco.com) is the first automotive retail group dedicated to deploying a coast-to-coast network of environmentally friendly franchised dealerships and vehicles. EVCARCO is bringing to market the most advanced clean technologies available in plug-in electric, alternative fuel, and pre-owned hybrid vehicles.
Research electric car stocks and green auto stocks , lithium stocks - with the renewable energy stocks directory Research over 1300 green stocks - Investors also have the option to access the directory as part of the Investor Ideas Investors also have the option to access the directory as part of the Investor Ideas Membership premium content that currently features an additional 10 stock directories, including the water stocks directory and all cleantech stock directories. http://www.investorideas.com/membership/
Investors - sign up for free stock alerts and investor news alerts
http://www.investorideas.com/Resources/Newsletter.asp
About Our Green Investor content:
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. Disclosure: Investorideas is compensated by featured green companies EVCARCO (OTCBB: EVCA) is a showcase stock at Investorideas.com and compensated the site 500,000 144 shares in lieu of cash compensation.
To become a showcase company, contact us below.
For more information contact:
Email: dvanzant@investorideas.com or Cali at cvanzant@investorideas.com
Source: www.Investorideas.com
Subscribe to:
Posts (Atom)